MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY COLLEGE LONDON on June 28, 2016. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Letter: Chronic active hepatitis induced by nitrofurantoin.
Letter: Hepatitis-B antigenaemia associated with active chronic hepatitis and mesangioproliferative glomerulonephritis.
Antibody to hepatitis B core antigen in chronic active hepatitis.
Ursodeoxycholic acid therapy in chronic active hepatitis.
Histologic study of chronic active hepatitis C; comparison with chronic active hepatitis B.
Letter: Liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.
Letter: Enhanced antibody responses in active chronic hepatitis.
Corticosteroid therapy for chronic active hepatitis.
Letter: Subacute and chronic active hepatitis after withdrawal of chemotherapy.
Letter: Hepatitis in patients with chronic renal failure.
Intrahepatic up-regulated expression of extracellular matrix protein receptors in chronic active hepatitis type B.
Monitoring of interferon-alpha treatment in chronic active hepatitis B.
Letter: apoptosis and hepatic fibrosis in chronic hepatitis B.
serum HBV DNA positive chronic active hepatitis type B.
Severe exacerbation of chronic active hepatitis B during interferon alpha therapy.
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Protective effect of hepatitis B virus-active antiretroviral therapy against primary hepatitis B virus infection.
Entecavir versus Lamivudine therapy for patients with chronic hepatitis B-associated liver failure: a meta-analysis.
Viral hepatitis type B: prospects for active immunization.
Serum IL-21 levels associated with chronic hepatitis B and hepatitis B-related liver failure.
Adverse effects of oral antiviral therapy in chronic hepatitis B.
Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy.
Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.
Letter: Chronic hepatitis.
Letter: Failure of transfer-factor therapy in chronic active type B hepatitis.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY COLLEGE LONDON on June 28, 2016. For personal use only. No other uses witho...
202KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Letter: Chronic active hepatitis induced by nitrofurantoin.
Letter: Hepatitis-B antigenaemia associated with active chronic hepatitis and mesangioproliferative glomerulonephritis.
Antibody to hepatitis B core antigen in chronic active hepatitis.
Ursodeoxycholic acid therapy in chronic active hepatitis.
Histologic study of chronic active hepatitis C; comparison with chronic active hepatitis B.
Letter: Liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.
Letter: Enhanced antibody responses in active chronic hepatitis.
Corticosteroid therapy for chronic active hepatitis.
Letter: Subacute and chronic active hepatitis after withdrawal of chemotherapy.
Letter: Hepatitis in patients with chronic renal failure.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms